Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Abacavir impairs an HLA-B*5701-restricted CD8+ T Cell response to an immunodominant Epstein-Barr virus epitope

Lucas, A., Meyer-Pannwitt, V., McKinnon, E., Burrows, S., Rist, M., Leary, S., Lucas, M., Mallal, S. and Phillips, E. (2013) Abacavir impairs an HLA-B*5701-restricted CD8+ T Cell response to an immunodominant Epstein-Barr virus epitope. In: 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013), 3 - 6 March 2013, Atlanta, Georgia

[img]
Preview
PDF (Poster)
Download (829kB) | Preview

Abstract

Background: Structural and functional studies show that abacavir (ABC) binds non-covalently to HLA B*57:01 and alters the repertoire of peptide presented, some of which may re-stimulate memory CD8+ T cells to cause ABC hypersensitivity. We questioned whether the binding of ABC to HLA-B*5701 might also impair an HLA-B*5701 restricted CD8+ T cell antiviral response.

Methods: 52 putative B95-8 Epstein-Barr Virus (EBV) strain HLA-B*57:01 restricted epitopes were identified using NetMHC 3.2 (binding score <400 nM). 7 healthy adult HLA-B*57:01+ donors were screened with EBV peptide pools followed by confirmatory enzyme-linked immunosorbent assay (ELISpot) with individual EBV peptides and avidity testing to 0.001 g/mL peptide. In addition, 4 HLA-B*57:01+ and 31 negative healthy donors were screened with 20-mer peptides overlapping with 15 amino acids from EBNA3A, 3B, BZLF1, and BMLF1. 4 short-term lines were generated from 4 HLA-B*57:01+ ABC-naīve donors by pulsing peripheral blood mononuclear cells (PBMC) with 20 μg/mL VSFIEFVGW for 1 hour, washing and then 9 days culture in RPMI-1640 media containing 10% FCS and 10% T-Stim media and 100 U/mL IL-2. The resulting cell lines contained 5% to 35% peptide specific CD8+ T cells. Cell lines or PBMC taken from HLA-B*57:01+ donors were tested for peptide specific responses ąABC at a range of concentrations previously shown not to affect cell viability, by intra-cellular cytokine re-stimulation assays (ICS) or ELISpot. Peptide concentrations of 0.01, 0.1, 1, and 10 g/mL were used in the ICS assay and 1 g/mL in the ELISpot assay. Expression of interferon (IFN)-γ in the presence of increasing concentrations of ABC relative to baseline (no ABC) and the respective ratios were analyzed using a linear mixed effects model with nesting for multiple peptide concentrations per individual.

Results: 4 HLA-B*57:01-restricted epitopes were confirmed of which 2 were independently detected using overlapping peptides: VSFIEFVGW from EBNA3A and VAAHPEIGAW from BMLF1. Responses to VSFIEFVGW were of high avidity and detectable in all 11 donors confirming it as an immunodominant peptide. IFN-γ responses to VSFIEFVGW relative to baseline were reduced relative to baseline with increasing abacavir concentrations using both ICS (Fig a) and ELISpot assay (Fig b).

Conclusions: A new immunodominant HLA-B*57:01-restricted EBV epitope was identified. ABC was shown to impair the CD8+ T cell response to this epitope in a dose-dependent manner, suggesting that drugs that bind non-covalently to HLA molecules may modulate immune responses.

Item Type: Conference Paper
Murdoch Affiliation(s): Institute for Immunology and Infectious Diseases
Conference Website: http://www.retroconference.org/2013/
Notes: Figures missing from abstract
URI: http://researchrepository.murdoch.edu.au/id/eprint/16144
Item Control Page Item Control Page

Downloads

Downloads per month over past year